Hide metadata

dc.date.accessioned2021-03-20T21:35:32Z
dc.date.available2021-03-20T21:35:32Z
dc.date.created2021-01-07T12:28:53Z
dc.date.issued2020
dc.identifier.citationEmilsson, Louise Semrad, Carol E. Lebwohl, Benjamin Green, Peter Ludvigsson, Jonas F. . Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease. Gastroenterology. 2020
dc.identifier.urihttp://hdl.handle.net/10852/84331
dc.description.abstractBackground & Aims The incidence of small bowel cancers is increasing. Associations have been made between celiac disease (CD) and small bowel cancers, but there have been no detailed studies of large cohorts. Methods Through the nationwide Epidemiology Strengthened by Histopathology Reports in Sweden cohort study, we retrieved data from Sweden’s 28 pathology departments on all individuals who received a diagnosis of CD from 1965 through 2017. Individuals with CD, defined as duodenal or jejunal villous atrophy (stage 3 Marsh score), were matched with as many as 5 randomly selected reference individuals from the general population. We used stratified Cox regression to calculate hazard ratios (HRs) for small bowel adenocarcinoma, adenomas, and carcinoids. Results During a median follow-up of 11 years, we identified 48,119 individuals with CD (patients) and 239,249 reference individuals. Beginning at 1 year after a diagnosis of CD, 29 patients (0.06%) received a diagnosis of small bowel adenocarcinoma vs 45 reference individuals (0.02%), 7 patients received a diagnosis of carcinoids vs 31 reference individuals, and 48 patients received a diagnosis of adenomas vs 50 reference individuals. Corresponding HRs were small bowel adenocarcinoma 3.05 (95% confidence interval [CI], 1.86–4.99), carcinoids 0.59 (95% CI, 0.16–2.10), and adenomas 5.73 (95% CI, 3.70–8.88). HRs were independent of sex and age. Overall, there was 1 extra case of small bowel adenocarcinoma in every 2944 patients with CD followed for 10 years. There was an inverse association between mucosal healing risk of future small bowel adenocarcinoma (HR, 0.18; 95% CI, 0.02–1.61), although the HR failed to attain statistical significance. Conclusions In an analysis of a nationwide pathology database in Sweden, we found the absolute risk of small bowel adenocarcinoma is low in individuals with CD. However, risks of small bowel adenocarcinoma and adenomas (but not carcinoids) are significantly increased in people with CD compared to people without this disease.
dc.languageEN
dc.publisherAmerican Gastroenterology Association Institute
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleRisk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease
dc.typeJournal article
dc.creator.authorEmilsson, Louise
dc.creator.authorSemrad, Carol E.
dc.creator.authorLebwohl, Benjamin
dc.creator.authorGreen, Peter
dc.creator.authorLudvigsson, Jonas F.
cristin.unitcode185,52,15,0
cristin.unitnameAvdeling for allmennmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1866983
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Gastroenterology&rft.volume=&rft.spage=&rft.date=2020
dc.identifier.jtitleGastroenterology
dc.identifier.volume159
dc.identifier.issue5
dc.identifier.startpage1686
dc.identifier.endpage1694.e2
dc.identifier.doihttps://doi.org/10.1053/j.gastro.2020.07.007
dc.identifier.urnURN:NBN:no-87078
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0016-5085
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/84331/1/Emilsson_CD_SMBC_Gastroenterology.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International